| Literature DB >> 35421978 |
S Lee Ware1, Christina R Studts2, Feitong Lei3, Heather Bush3, Eric B Higgins1, Jamie L Studts4,5, Ana Bastos de Carvalho6.
Abstract
BACKGROUND: Diabetic retinopathy (DR) is a leading cause of blindness worldwide, despite easy detection and effective treatment. Annual screening rates in the USA remain low, especially for the disadvantaged, which telemedicine-based DR screening (TDRS) during routine primary care has been shown to improve. Screening rates from such programs have varied, however, pointing to inconsistent implementation and unaddressed barriers. This work seeks to identify and prioritize modifiable barriers for targeted intervention.Entities:
Keywords: Barriers and facilitators; Classification and regression tree (CART); Consolidated framework for implementation research (CFIR); Determinants; Diabetic retinopathy; Mixed methods; Primary care; Screening; Telemedicine; Underserved
Mesh:
Year: 2022 PMID: 35421978 PMCID: PMC9011929 DOI: 10.1186/s12913-022-07915-5
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.908
Respondent demographic, professional, and intervention-specific characteristics by professional stratum
| Respondent, Clinic Characteristics (n) | Providers (%) | Staff (%) | |
|---|---|---|---|
| .002 | |||
| Female (119) | 29 (83) | 90 (98) | |
| Male (8) | 6 (17) | 2 (2) | |
| .739 | |||
| 18-30 years (22) | 4 (11) | 18 (20) | |
| 31-45 years (51) | 14 (40) | 37 (40) | |
| 46-65 years (49) | 16 (46) | 33 (36) | |
| > 65 years (4) | 1 (3) | 3 (3) | |
| Prefer not to specify (1) | 0 | 1 (1) | |
| .038 | |||
| White, non-Hispanic (98) | 32 (91) | 66 (71) | |
| Black or African American (11) | 0 | 11 (12) | |
| Hispanic or Latino (10) | 0 | 10 (11) | |
| Asian (6) | 3 (9) | 3 (3) | |
| American Indian or Alaska native (1) | 0 | 1 (1) | |
| Prefer not to specify (1) | 0 | 1 (1) | |
| N/A | |||
| High school diploma (1) | 0 | 1 (1) | |
| Some college (21) | 0 | 21 (23) | |
| 2-year degree (50) | 0 | 50 (54) | |
| 4-year degree (7) | 0 | 7 (8) | |
| Professional degree (32) | 22 (63) | 10 (11) | |
| Doctorate (13) | 13 (37) | 0 | |
| Prefer not to specify (3) | 0 | 3 (3) | |
| .968 | |||
| 0-5 years (46) | 12 (34) | 34 (37) | |
| 6-10 years (26) | 7 (20) | 19 (21) | |
| 11-20 years (19) | 6 (17) | 13 (14) | |
| More than 20 years (36) | 10 (29) | 26 (28) | |
| .645 | |||
| < 1 year (23) | 6 (17) | 17 (18) | |
| 1-5 years (55) | 17 (47) | 38 (39) | |
| 6-10 years (23) | 7 (19) | 16 (16) | |
| > 10 years (32) | 6 (17) | 26 (27) | |
| .030 | |||
| < 1 year (60) | 9 (25) | 51 (54) | |
| 1-2 years (25) | 9 (25) | 16 (17) | |
| 3-5 years (43) | 16 (44) | 27 (28) | |
| > 5 years (3) | 2 (6) | 1 (1) | |
| .004 | |||
| Desktop/Tabletop (80) | 23 (64) | 57 (59) | |
| Handheld/Portable (33) | 3 (8) | 30 (31) | |
| Both (7) | 2 (6) | 5 (5) | |
| Unsure (13) | 8 (22) | 5 (5) |
Abbreviations: TDRS telemedicine diabetic retinopathy screening
*P-values were generated from chi-square test
Responses to key measures of TDRS utilization by professional stratum
| Survey Item, responses (n) | Providers (%) | Staff (%) |
|---|---|---|
| What percentage of eligible patients did you screen? | ||
| 0-25% (51) | 11 (31) | 40 (42) |
| 26-50% (24) | 4 (11) | 20 (21) |
| 51-75% (19) | 7 (19) | 12 (13) |
| > 75% (20) | 10 (28) | 10 (10) |
| Unsure (18) | 4 (11) | 14 (15) |
| How frequently do you use TS for your patients? | ||
| Daily (29) | 7 (19) | 22 (23) |
| Weekly (48) | 13 (36) | 35 (37) |
| Monthly (23) | 9 (25) | 14 (15) |
| Less than once per month (30) | 7 (19) | 23 (24) |
| Please rate your overall satisfaction with TS. | ||
| Very satisfied (41) | 13 (36) | 28 (30) |
| Satisfied (83) | 22 (61) | 61 (65) |
| Dissatisfied (6) | 1 (3) | 5 (5) |
| What percentage of your diabetic patients do you think got their recommended screening for diabetic eye disease in the last year [whether in your clinic through TS, or elsewhere by an eye care provider]? | ||
| 0-25% (33) | 6 (17) | 27 (28) |
| 26-50% (33) | 5 (14) | 28 (29) |
| 51-75% (44) | 21 (58) | 23 (24) |
| > 75% (11) | 4 (11) | 7 (7) |
| Unsure (11) | 0 | 11 (11) |
Abbreviations: TDRS and TS telemedicine diabetic retinopathy screening
Variables significantly associated with screening performance
| Variable Label (n) | LS Group | HS Group | OR | 95% CI | |
|---|---|---|---|---|---|
| Experience with TDRS? | 0.008 | ||||
| > 2 years (40) | 11 (27.5) | 29 (72.5) | 3.1 | 1.4—7.1 | |
| 2 or fewer years (74) | 40 (54.0) | 34 (46.0) | REF | ||
| Frequency of use? | <.0001 | ||||
| At least weekly (72) | 20 (27.8) | 52 (72.2) | 16.5 | 4.4—61.8 | |
| Monthly (19) | 11 (57.9) | 8 (42.1) | 4.6 | 1.0—21.1 | |
| Less than once per month (22) | 19 (86.4) | 3 (13.6) | REF | ||
| Why not: Patient Objection? | 0.0003 | ||||
| No (50) | 32 (64.0) | 18 (36.0) | 0.2 | 0.1—0.5 | |
| Yes (64) | 19 (29.7) | 45 (70.3) | REF | ||
| Champion: present, effective? | 0.0545 | ||||
| Yes, very effective (29) | 8 (27.6) | 21 (72.4) | 2.0 | 0.8—5.3 | |
| Yes, moderately effective or ineffective (16) | 11 (68.8) | 5 (31.2) | 0.3 | 0.1—1.0 | |
| Not present (64) | 28 (43.8) | 36 (56.2) | REF | ||
| Are patients compliant with screening guidelines? | <.0001 | ||||
| 0-25% (29) | 23 (79.3) | 6 (20.7) | 0.1 | 0.0—0.2 | |
| 26-50% (29) | 13 (44.8) | 16 (55.2) | 0.3 | 0.1—0.9 | |
| > 50% (50) | 11 (22.0) | 39 (78.0) | REF | ||
| Effective reminder/alert in place? | 0.0101 | ||||
| Yes (59) | 19 (32.2) | 40 (67.8) | 2.8 | 1.3—6.0 | |
| No (51) | 29 (56.9) | 22 (43.1) | REF | ||
| Standing order? | 0.0024 | ||||
| Unsure (21) | 17 (81.0) | 4 (19.0) | 0.2 | 0.1—0.7 | |
| Yes (63) | 21 (33.3) | 42 (66.7) | 1.5 | 0.6—3.8 | |
| No (26) | 11 (42.3) | 15 (57.7) | REF | REF | |
| Workflow present? | 0.0014 | ||||
| Yes (77) | 26 (33.8) | 51 (66.2) | 3.9 | 1.7—9.1 | |
| No (36) | 24 (66.7) | 12 (33.3) | REF | ||
| aExplicit positive instructions? | 0.0554 | ||||
| Always/Very frequently (58) | 23 (39.7) | 35 (60.3) | 6.8 | 1.4—34.6 | |
| Rarely/Never (22) | 15 (68.2) | 7 (31.8) | REF | ||
| aStaff autonomy? | 0.0485 | ||||
| Yes (51) | 20 (39.2) | 31 (60.8) | 2.6 | 1.0—6.9 | |
| No (27) | 17 (63.0) | 10 (37.0) | REF | ||
| bWhy not: Running behind? | 0.0053 | ||||
| No (11) | 3 (27.3) | 8 (72.7) | 7.9 | 1.2—51.8 | |
| Yes (21) | 13 (61.9) | 8 (38.1) | REF |
Abbreviations: TDRS telemedicine diabetic retinopathy screening, LS lower screening, HS higher screening, OR estimated odds ratio, CI confidence interval
aResponses restricted to staff only (n = 82)
bResponses restricted to providers only (n = 32)
#P-values were obtained from univariate logistic regression model
Fig. 1Primary classification tree for modifiable determinants of TDRS performance. Abbreviations: TDRS and TS, telemedicine diabetic retinopathy screening
Fig. 2Convergence of determinants associated with TDRS performance upon aligned CFIR constructs. Abbreviations: CFIR, Consolidated Framework for Implementation Research; TDRS, telemedicine diabetic retinopathy screening; CART, Classification and Regression Tree; VIR, variable importance ranking. The Phase III variable ranking was determined from each variable’s VIR value in the primary or secondary CART model